chr21-32582391-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_144659.7(TCP10L):c.169C>T(p.Leu57Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000434 in 1,613,440 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_144659.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TCP10L | NM_144659.7 | c.169C>T | p.Leu57Phe | missense_variant | 3/5 | ENST00000300258.8 | NP_653260.1 | |
CFAP298-TCP10L | NR_146638.2 | n.825C>T | non_coding_transcript_exon_variant | 6/11 | ||||
CFAP298-TCP10L | NM_001350338.2 | c.691C>T | p.Leu231Phe | missense_variant | 6/8 | NP_001337267.1 | ||
CFAP298-TCP10L | NR_146639.2 | n.825C>T | non_coding_transcript_exon_variant | 6/12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TCP10L | ENST00000300258.8 | c.169C>T | p.Leu57Phe | missense_variant | 3/5 | 1 | NM_144659.7 | ENSP00000300258 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152064Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000200 AC: 5AN: 250576Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135418
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1461258Hom.: 0 Cov.: 31 AF XY: 0.00000413 AC XY: 3AN XY: 726896
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152182Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74382
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 30, 2022 | The c.169C>T (p.L57F) alteration is located in exon 3 (coding exon 2) of the TCP10L gene. This alteration results from a C to T substitution at nucleotide position 169, causing the leucine (L) at amino acid position 57 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at